In a review of current facts about the antiviral drug Paxlovid, Susan Ellenberg, PhD, comments on Pfizer’s unusual release of interim results during an ongoing clinical trial.
In a review of current facts about the antiviral drug Paxlovid, Susan Ellenberg, PhD, comments on Pfizer’s unusual release of interim results during an ongoing clinical trial.